PP_1170x120_10-25-21

HDA Foundation

Cowman and O’Dowd to lead HDA Research Foundation board

Cowman and O’Dowd to lead HDA Research Foundation board

ARLINGTON, Va. — The HDA Research Foundation announced Craig Cowman of Cardinal Health as chairman of its board of directors. Stephen O’Dowd of Eisai, Inc., is vice chairman. Cowman, who served as the Foundation vice chair for the past two years, assumes leadership of the board from Michael Conley, who retired from Novartis Pharmaceuticals at

HDA Foundation study looks at Rx product serialization

HDA Foundation study looks at Rx product serialization

ARLINGTON, Va. — The pharmaceutical supply chain’s progress on implementing product serialization requirements to comply with the Drug Supply Chain Security Act (DSCSA) has slowed as the November 2023 deadline for compliance comes into view. According to the HDA Research Foundation’s latest Serialization Readiness Survey, trading partners appear to be deferring their DSCSA-related investments into

Conley and Cowman to lead HDA Foundation board of directors

Conley and Cowman to lead HDA Foundation board of directors

ARLINGTON, Va. — The HDA Research Foundation announced Michael Conley, vice president and head, trade operations and analytics, Novartis Pharmaceuticals Corp., as chairman of its board of directors. Craig Cowman, executive vice president, global sourcing, Cardinal Health, is vice chairman. Conley, formerly the vice chairman for the foundation, assumes the role from Charles (Chip) Phillips,